Cargando…

Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women

OBJECTIVE: The development of osteoporosis is associated with several risk factors, such as genetic structures that affect bone turnover and bone mass. The impact of genetic structures on osteoporosis is not known. Plasminogen activator inhibitor type-1 regulates the bone matrix and bone balance. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozgen, Merih, Cosan, Didem Turgut, Doganer, Fulya, Soyocak, Ahu, Armagan, Onur, Gunes, Hasan Veysi, Degirmenci, Irfan, Ozkara, Gulsah Ogutler, Mutlu, Fezan Sahin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488989/ https://www.ncbi.nlm.nih.gov/pubmed/23184207 http://dx.doi.org/10.6061/clinics/2012(11)13

Ejemplares similares

Is there any association between osteoporotic vertebral fracture and vitamin K epoxide reductase complex subunit-1 polymorphism in Turkish society? A pilot study
por: Ozgen, Merih, et al.
Publicado: (2019)

Genetic variation in NOD1/CARD4 and NOD2/CARD15 immune sensors and risk of osteoporosis
por: Soyocak, Ahu, et al.
Publicado: (2020)

The Effects of Monosodium Glutamate and Tannic Acid on Adult Rats
por: Ugur Calis, Ibrahim, et al.
Publicado: (2016)

Frequency of angiotensin II type 1 receptor gene polymorphism in Turkish acute stroke patients
por: Hulyam, Kurt, et al.
Publicado: (2013)

Rehabilitation cost share and cost analysis of traumatic hand injuries: Our single-center results
por: Özgen, Merih, et al.
Publicado: (2021)

Effects of placebo-controlled continuous and pulsed ultrasound treatments on carpal tunnel syndrome: a randomized trial
por: Armagan, Onur, et al.
Publicado: (2014)

Comparing the efficacy of continuous and pulsed ultrasound therapies in patients with lateral epicondylitis: A double-blind, randomized, placebo-controlled study
por: Hüseyin Ünver, Hasan, et al.
Publicado: (2021)

A randomized-controlled clinical trial comparing the effects of steroid phonophoresis and therapeutic ultrasound in carpal tunnel syndrome
por: Ortanca, Burcu, et al.
Publicado: (2022)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer
por: Öner, Çağrı, et al.
Publicado: (2016)

The relationship between quality of life and fear of Turkish individuals during the COVID-19 pandemic: A cross-sectional study
por: Aksoy, Ahu, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
por: Alotaibi, Fahad T., et al.
Publicado: (2019)

Three Single Nucleotide Polymorphisms of LOXL1’ in a Turkish Population with Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma
por: Yaz, Yetkin, et al.
Publicado: (2018)

Inhalation Therapy of Calcitonin Relieves Osteoarthritis of the Knee
por: Armagan, Onur, et al.
Publicado: (2012)

The prosthesis evaluation questionnaire: reliability and cross-validation of the Turkish version
por: Safer, Vildan Binay, et al.
Publicado: (2015)

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
por: White, Marquitta J., et al.
Publicado: (2015)

Gastric Expression of Plasminogen Activator Inhibitor (PAI)-1 Is Associated with Hyperphagia and Obesity in Mice
por: Kenny, Susan, et al.
Publicado: (2013)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

Rare childhood tumors in a Turkish pediatric oncology center
por: Tacyildiz, Nurdan, et al.
Publicado: (2013)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
por: Lampelj, Maja, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
por: Pierga, J. Y., et al.
Publicado: (1997)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice()
por: Gamble, Joanne, et al.
Publicado: (2013)

Criteria and Search for Specific Assays for Active Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma
por: Kluft, C.
Publicado: (2000)

Validity and reliability of the Turkish version of the Michigan Neuropathy Screening Instrument
por: AKTAR REYHANİOĞLU, Duygu, et al.
Publicado: (2020)

Role of increased plasminogen activator inhibitor-1 and vitronectin in gestational diabetes mellitus
por: Ozgen, Levent, et al.
Publicado: (2023)

Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix
Publicado: (1991)

Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells
Publicado: (1987)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Evaluation of Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM
por: Polat, Sefika Burcak, et al.
Publicado: (2014)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
por: Mennesson, Marie, et al.
Publicado: (2023)

PSUN171 CORRELATIONS BETWEEN SERUM AND TEAR PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) AND TISSUE PLASMINOGEN ACTIVATOR (tPA) IN PATIENTS WITH DIABETIC RETINOPATHY
por: Jasmiad, Nurbadriah, et al.
Publicado: (2022)

Fibronectin, Plasminogen Activator Inhibitor Type 1 (PAI-1) And Uterine Artery Doppler Velocimetry as Markers of Preeclampsia
por: Bodova, Kristina Biskupska, et al.
Publicado: (2011)

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent
por: Hohensinner, Philipp J., et al.
Publicado: (2017)

Turkish Neonatal Society guideline on the transfusion principles in newborns
por: Çetinkaya, Merih, et al.
Publicado: (2018)

Increased expression of urokinase type plasminogen activator(u-PA), plasminogen activator inhibitor-1(PAI-1), and collagenases in Caco-2 cells infected by Salmonella typhimurium.
por: Park, C. G., et al.
Publicado: (1997)

Investigation of third molar impaction in Turkish orthodontic patients: Prevalence, depth and angular positions
por: Topkara, Ahu, et al.
Publicado: (2013)

Urokinase Plasminogen Activator Receptor (uPAR) and Plasminogen Activator Inhibitor-1 (PAI-1) Are Potential Predictive Biomarkers in Early Stage Oral Squamous Cell Carcinomas (OSCC)
por: Magnussen, Synnøve, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2lp3qcj76h52k3cnn5g0v3b4gc